Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams Acquires 34,000 Shares

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams purchased 34,000 shares of the firm's stock in a transaction dated Friday, April 4th. The shares were bought at an average price of $0.99 per share, for a total transaction of $33,660.00. Following the completion of the transaction, the director now owns 4,754,800 shares of the company's stock, valued at approximately $4,707,252. This trade represents a 0.72 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website.

Gregg Williams also recently made the following trade(s):

• On Friday, April 11th, Gregg Williams acquired 2,311 shares of Vivani Medical stock. The shares were purchased at an average cost of $1.01 per share, with a total value of $2,334.11.
• On Wednesday, April 9th, Gregg Williams bought 18,529 shares of Vivani Medical stock. The stock was purchased at an average price of $1.02 per share, for a total transaction of $18,899.58.
• On Monday, April 7th, Gregg Williams purchased 44,400 shares of Vivani Medical stock. The shares were purchased at an average price of $0.99 per share, with a total value of $43,956.00.
• On Wednesday, April 2nd, Gregg Williams acquired 2,000 shares of Vivani Medical stock. The stock was acquired at an average price of $1.01 per share, for a total transaction of $2,020.00.

Vivani Medical Stock Performance

Vivani Medical stock traded up $0.01 during mid-day trading on Friday, hitting $1.02. 54,177 shares of the company traded hands, compared to its average volume of 170,112. Vivani Medical, Inc. has a one year low of $0.91 and a one year high of $2.09. The stock has a market cap of $60.42 million, a price-to-earnings ratio of -2.27 and a beta of 2.76. The stock has a fifty day moving average price of $1.09 and a 200-day moving average price of $1.19.

Vivani Medical (NASDAQ:VANI - Get Free Report) last announced its earnings results on Monday, March 31st. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.01). Sell-side analysts predict that Vivani Medical, Inc. will post -0.41 EPS for the current year.

Hedge Funds Weigh In On Vivani Medical

Institutional investors have recently modified their holdings of the company. Wealthedge Investment Advisors LLC bought a new stake in Vivani Medical in the 4th quarter worth approximately $43,000. Jane Street Group LLC purchased a new position in shares of Vivani Medical during the fourth quarter worth approximately $66,000. Northern Trust Corp raised its stake in shares of Vivani Medical by 19.1% during the fourth quarter. Northern Trust Corp now owns 71,915 shares of the company's stock worth $83,000 after acquiring an additional 11,540 shares in the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Vivani Medical by 4.6% in the 3rd quarter. Geode Capital Management LLC now owns 342,891 shares of the company's stock worth $401,000 after acquiring an additional 15,008 shares during the last quarter. 6.78% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, HC Wainwright reaffirmed a "buy" rating and issued a $4.00 price target on shares of Vivani Medical in a report on Friday, April 4th.

Vivani Medical Company Profile

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.